KLRK1 and glioblastoma: In NKG2D-intact mice, γδ T cells produced more IFN-γ upon treatment with TMZ, proving that TMZ treatment facilitated enhanced Vγ9Vδ2 T-cell-mediated GBM cell killing [24].